122.20 USD
-3.88
3.08%
At close Jun 13, 4:00 PM EDT
After hours
122.20
+0.00
0.00%
1 day
-3.08%
5 days
-4.95%
1 month
-8.05%
3 months
-9.12%
6 months
-26.47%
Year to date
-19.04%
1 year
-25.69%
5 years
18.59%
10 years
716.30%
 

About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Employees: 3,000

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

67% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 36

10% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 106

6% more funds holding

Funds holding: 301 [Q4 2024] → 320 (+19) [Q1 2025]

0% more call options, than puts

Call options by funds: $524K | Put options by funds: $524K

0.85% less ownership

Funds ownership: 99.06% [Q4 2024] → 98.21% (-0.85%) [Q1 2025]

17% less capital invested

Capital invested by funds: $5.43B [Q4 2024] → $4.52B (-$919M) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for NOVT.

Financial journalist opinion

Neutral
Business Wire
2 days ago
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial.
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
Neutral
Business Wire
1 month ago
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
Neutral
Business Wire
1 month ago
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, in Chicago, IL. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial origi.
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
Neutral
Seeking Alpha
1 month ago
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q1 2025 Results Conference Call May 6, 2025 10:00 AM ET Company Participants Ray Nash - Investor Relations Matthijs Glastra - Chair & Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Gary, and I will be your conference operator today.
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Novanta (NOVT) Q1 Earnings Beat Estimates
Novanta (NOVT) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.74 per share a year ago.
Novanta (NOVT) Q1 Earnings Beat Estimates
Neutral
Business Wire
1 month ago
Novanta Announces Financial Results for the First Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) March 28,     March 29,     2025     2024   GAAP           Revenue $ 233.4     $ 230.9   Operating Income $ 32.4     $ 25.6   Net Income $ 21.2     $ 14.7   Diluted EPS $ 0.59     $ 0.
Novanta Announces Financial Results for the First Quarter 2025
Neutral
Business Wire
2 months ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2025 results on Tuesday, May 6, 2025. The Company will host a conference call on Tuesday, May 6, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a l.
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025
Neutral
Seeking Alpha
3 months ago
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
3 months ago
Novanta (NOVT) Q4 Earnings Beat Estimates
Novanta (NOVT) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago.
Novanta (NOVT) Q4 Earnings Beat Estimates
Neutral
Business Wire
3 months ago
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights Three Months Ended December 31,   Year Ended December 31, (In millions, except per share amounts)   2024       2023       2024       2023   GAAP                       Revenue $ 238.1     $ 211.6     $ 949.2     $ 881.7   O.
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
Charts implemented using Lightweight Charts™